Stemline Therapeutics Inc (NASDAQ:STML) Investor Investigation Announced
An investigation on behalf of current long-term investors in shares of Stemline Therapeutics Inc (NASDAQ:STML) was announced over potential breaches of fiduciary duties by certain officers and directors at Stemline Therapeutics Inc.
View full press release